News & Events
- December 1, 2017
-
December 1, 2017
Emerging Good Practices for Translatability Assessment (TA) of Patient-Reported Outcome (PRO) Measures
Acquadro C, Patrick D, Eremenco S, Martin M, Kuliś D, Correia H, et al. Emerging good practices for Translatability Assessment (TA) of Patient-Reported Outcome (PRO) measures. Journal of Patient-Reported Outcomes. 2017;(2):8.
-
December 1, 2017
Patient-Reported Outcome (PRO) Consortium Translation Process: Consensus Development of Updated Best Practices
Eremenco S, Pease S, Mann S, Berry P, on behalf of the PRO Consortium’s Process Subcommittee. Patient-Reported Outcome (PRO) Consortium translation process: consensus development of updated best practices. Journal of Patient-Reported Outcomes. 2017;(2):12.
-
November 24, 2017
Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development
Steinhorn R, Davis JM, Göpel W, Jobe A, Abman S, Laughon M, Bancalari E, Aschner J, Ballard R, Greenough A, Storari L, Thomson M, Ariagno RL, Fabbri L, Turner MA. Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development. The Journal of Pediatrics. 2017 Dec 1;191:15–21.e1.
-
November 22, 2017
HD-RSC Kick-off: Charles Sabine Presentation
The kickoff meeting for a new dedicated worldwide consortium focused on Huntington’s disease took place on November 6 and 7 in Silver Spring, Maryland. The goal of this meeting was to gather relevant stakeholders to align on the purpose and potential opportunities which could benefit from precompetitive collaboration for accelerating HD therapeutics. · The Kickoff...
